https://orcid.org/0000-0002-7871-9846
References
- Weber J , Mandala M , Del Vecchio M et al. Adjuvant nivolumab versus ipilimumab in resected stage III or IV melanoma. N. Engl. J. Med. 377, 1824–1835 (2017).
- Long GV , Hauschild A , Santinami M , Atkinson V et al. Adjuvant dabrafenib plus trametinib in stage III BRAF-mutated melanoma. N. Engl. J. Med. 377, 1813–1823 (2017).
- Weber JS , D’Angelo SP , Minor D et al. Nivolumab versus chemotherapy in patients with advanced melanoma who progressed after anti-CTLA-4 treatment (CheckMate 037): a randomised, controlled, open-label, phase 3 trial. Lancet Oncol. 16, 375–384 (2015).
- Larkin J , Minor D , D’Angelo S et al. Overall survival in patients with advanced melanoma who received nivolumab versus investigator’s choice chemotherapy in CheckMate 037: a randomized, controlled, open-label Phase III trial. J. Clin. Oncol. 36, 383–390 (2018).
- Robert C , Schachter J , Long GV et al. Pembrolizumab versus ipilimumab in advanced melanoma. N. Engl. J. Med. 372(26), 2521–2532 (2015).
- Andtbacka RH , Kaufman HL , Collichio F et al. Talimogene laherparepvec improves durable response rate in patients with advanced melanoma. J. Clin. Oncol. 33(25), 2780–2788 (2015).
- Moreno-Ramirez D , de la Cruz-Merino L , Ferrandiz L , Villegas-Portero R , Nieto-Garcia A . Isolated limb perfusion for malignant melanoma: systematic review on effectiveness and safety. Oncologist 15(4), 416–427 (2010).
- Sersa G , Miklavcic D , Cemazar M , Rudolf Z , Pucihar G , Snoj M . Electrochemotherapy in treatment of tumours. Eur. J. Surg. Oncol. 34(2), 232–240 (2008).
- Jarm T , Cemazar M , Miklavcic D , Sersa G . Antivascular of electrochemotherapy: implications in treatment of bleeding metastases. Expert Rev. Anticancer Ther. 10(5), 729–746 (2010).
- Falk H , Lambaa S , Hjort Johannesen H , Wooler G , Venzo A , Gehl J . Electrochemotherapy and calcium electroporation inducing a systemic immune response with local and distant remission of tumors in a patient with malignant melanoma - a case report. Acta Oncol. 56(8), 1126–1131 (2017)
- Morley J , Grocott P , Pursell E , Murrells T . Electrochemotherapy for the palliative management of cutaneous metastases: a systematic review and meta-analysis. Eur. J. Surg. Oncol. 45(12), 2257–2267 (2019)
- Mali B , Jarm T , Snoj M , Sersa G , Miklavcic D . Antitumor effectiveness of electrochemotherapy: a systematic review and meta-analysis. Eur. J. Surg. Oncol. 39(1), 4–16 (2013)
- Mir LM , Gehl J , Sersa G et al. Standard operating procedures of the electrochemotherapy: instructions for the use of bleomycin or cisplatin administered either systemically or locally and electric pulses delivered by the Cliniporator (TM) by means of invasive or non-invasive electrodes. Eur. J. Cancer Suppl. 4, 14–25 (2006)
- Gehl J , Sersa G , Matthiessen et al. Updated standard operating procedures for electrochemotherapy of cutaneous tumours and skin metastases. Acta Oncol. 57, 874–882 (2018)
- Regionala Cancercenter i samverkan . Nationellt vårdprogram Malignt melanom 2019. https://kunskapsbanken.cancercentrum.se/diagnoser/melanom/vardprogram/systemisk-behandling/#chapter-11-3-1-6-Elektrokemoterapi
- Theurich S , Rothschild SI , Hoffmann M et al. Local tumor treatment in combination with systemic ipilimumab immunotherapy prolongs overall survival in patients with advanced malignant melanoma. Cancer Immunol. Res. 4, 744–754 (2016).
- Campana LG , Peric B , Mascherini M et al. Combination of pembrolizumab with electrochemotherapy in cutaneous metastases from melanoma: a comparative retrospective study from the InspECT and Slovenian Cancer Registry. Cancer 13(17), 4289 (2021).
- Valpione S , Campana LG , Pigozzo J , Chiarion-Sileni V . Consolidation electrochemotherapy with bleomycin in metastatic melanoma during treatment with dabrafenib. Radiol. Oncol. 49, 71–74 (2015).
- Dolinsek T , Prosen L , Cemazar M , Potocnik T , Sersa G . Electrochemotherapy with bleomycin is effective in BRAF mutated melanoma cells and interacts with BRAF inhibitors. Radiol. Oncol. 50, 274–279 (2016).
- Gallagher Chin KY , MacKenzie-Ross A . Bleomycin electrochemotherapy for the management of locally advanced metastatic melanoma: two notable clinical cases potentially indicating a greater therapeutic role in the era of targeted and immuno-therapy. JPRAS Open 26, 43–48 (2020).